• AAPM Abstract Submission Form

    Deadline to submit: November 11, 2026
  • Submit your pain medicine abstract to PainConnect 2027 and share your research with top professionals. Expand the wealth of knowledge and shape the future of pain care. Abstract submissions provide new insights to improve the knowledge, competence, and performance of Pain Medicine practice, offering innovative solutions to current challenges and furthering the Academy's overall mission. For more detailed information on submitting your poster, visit the PainConnect Call for Abstracts Page.

    • Primary Presenter 
    • Format: (000) 000-0000.
    • My Products

      prevnext( X )
      PainConnect 2027 Industry Poster Submission. $2,500 will be charged for all industry posters upon submission and includes one full conference registration. If your abstract is not accepted, you will receive a full refund. If the American Academy of Pain Medicine accepts your abstract, there will be no refunds.
      PainConnect 2027 Industry Poster Submission

      $2,500 will be charged for all industry posters upon submission and includes one full conference registration. If your abstract is not accepted, you will receive a full refund. If the American Academy of Pain Medicine accepts your abstract, there will be no refunds.

      $2,500.00$2,500.00
        
      Total
      $0.00$0.00

      Debit or Credit Card
    • Co-Presenter 
    • Format: (000) 000-0000.
    • Co-Presenter 2 
    • Format: (000) 000-0000.
    • Co-Presenter 3 
    • Format: (000) 000-0000.
    • Collapse Stopper 
    • Browse Files
      Drag and drop files here
      Choose a file
      Cancelof
    • For questions, please email rosa.mckenzie@scorah.net.

    • Disclosures

    • Do any of the authors of this abstract have any commercial relationships to disclose? - If yes, please complete the Disclosure of Commercial Relationships.*
    • Is any device or drug required FDA approval identified as an important component of your presentation? - If yes, please complete the FDA Disclosure Form.*
    • Date
       - -
      2 digit month, 2 digit day, 4 digit year
    • By submitting this abstract, the presenting author certifies the following:

      The identical abstract has not been submitted to any other meeting. The material has not been accepted for publication prior to this submission. All the listed presenters have reviewed this abstract and agree to its submission. Upon acceptance, the presenting author accepts the commitment to possibly present the abstract from the podium at the AAPM 2027 PainConnect Conference. Note: By submitting a scientific poster abstract, you agree that you, or a co-author designated by you at the time of submission, will present the abstract digitally during the Annual Meeting. Poster presenters must register for the entire Annual Meeting before the session is formally accepted and scheduled. Poster presenters are responsible for all expenses incurred in registering for, traveling to, and attending the Annual Meeting.
    • Presenter Biographical Form

      This information must be submitted for the Primary Presenter only. Please type the information with your name and credentials exactly as you want them to appear in the published materials.
    • Format: (000) 000-0000.
    • Format: (000) 000-0000.
    • Format: (000) 000-0000.
    • Disclosure of Financial Relationships

      All authors submitting abstracts for publications are required to disclose any relationships with industry that may direct bearing on relevant subject matter. The primary presenter must disclose any author/presenter who has relevant financial interest or other relationships occurring with the past 12 months with commercial companies or organizations.
    • Rows
    • Additional Form if needed 
    • Rows
    • Additional Form if needed 
    • Rows
    • Additional Form if needed 
    • Rows
    • Collapse Stopper 
    • FDA Disclosure

      If a device or drug requiring FDA approval is identified as an important component of your presentation, please list the device/drug and indicate the FDA status as either: Approved, Investigational Device/Drug, Not approved for distribution in the United States.
    • Device/Drug Status

    • Device/Drug Status

    • Device/Drug Status

    • Device/Drug Status

    • Device/Drug Status

    • Device/Drug Status

    • Should be Empty: